Respiratory Infections, Acute

Respiratory
1
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
3 programs
1
ZincPhase 31 trial
RSV Disease in the ElderlyN/A1 trial
RSV challenge materialN/A1 trial
Active Trials
NCT00246480CompletedEst. May 2008
NCT00100373CompletedEst. May 2005
NCT00133432Terminated

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Allergy TherapeuticsZinc
Allergy TherapeuticsRSV Disease in the Elderly
Allergy TherapeuticsRSV challenge material

Clinical Trials (3)

Zinc and Pneumonia Protocol

Start: Sep 2005
Phase 3Terminated
NCT00246480Allergy TherapeuticsRSV Disease in the Elderly

RSV Disease in the Elderly

Start: Oct 2005Est. completion: May 2008
N/ACompleted
NCT00100373Allergy TherapeuticsRSV challenge material

RSV Challenge in Healthy Adults

Start: Sep 2004Est. completion: May 2005
N/ACompleted

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space